These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 6210171)

  • 41. Some newer aspects of the carcinoid syndrome.
    Eiband JM; Brown H; Gregory CH; Kahil ME
    Tex Med; 1966 Dec; 62(12):62-5. PubMed ID: 5980426
    [No Abstract]   [Full Text] [Related]  

  • 42. [A functioning carcinoid tumor with liver involvement without the associated carcinoid syndrome].
    Sánchez A; Bataller R; Alós L; Ginés A; Bruguera M; Rodés J
    Gastroenterol Hepatol; 1995 Nov; 18(9):468-70. PubMed ID: 8521224
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Classification of low-grade neuroendocrine tumors of midgut and unknown origin.
    Van Eeden S; Quaedvlieg PF; Taal BG; Offerhaus GJ; Lamers CB; Van Velthuysen ML
    Hum Pathol; 2002 Nov; 33(11):1126-32. PubMed ID: 12454818
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Valproic acid activates notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells.
    Greenblatt DY; Vaccaro AM; Jaskula-Sztul R; Ning L; Haymart M; Kunnimalaiyaan M; Chen H
    Oncologist; 2007 Aug; 12(8):942-51. PubMed ID: 17766653
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gastrointestinal carcinoid tumors: 10-year experience of a general surgical department.
    Karatzas G; Kouskos E; Kouraklis G; Mantas D; Papachristodoulou A
    Int Surg; 2004; 89(1):21-6. PubMed ID: 15085993
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The relationship between 5-hydroxyindoles and catecholamines.
    O'Reilly S; Cooksey B
    Neurology; 1965 Dec; 15(12):1142-6. PubMed ID: 5893581
    [No Abstract]   [Full Text] [Related]  

  • 47. Transcatheter arterial chemoembolization with DSM for primary hepatic malignant carcinoid.
    Hijioka S; Ikari T; Kamei A; Takano K; Asahara S; Fujita N; Shimizu M; Kuraoka K; Fijita R; Kanda H; Kato Y
    Hepatogastroenterology; 2007 Mar; 54(74):382-5. PubMed ID: 17523279
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The analysis of immunophenotype of gastrin-producing tumors of the pancreas and gastrointestinal tract.
    Gurevich L; Kazantseva I; Isakov VA; Korsakova N; Egorov A; Kubishkin V; Bulgakov G
    Cancer; 2003 Nov; 98(9):1967-76. PubMed ID: 14584081
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Biochemical and morphologic studies on the accumulation of serotonin in the carcinoid syndrome].
    May B; Bak IJ
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(2):175. PubMed ID: 4239209
    [No Abstract]   [Full Text] [Related]  

  • 50. [Carcinoid tumor. Hepatic metastiasis].
    Alessandri H; Moya E; Carranza C; Donoso S; Csendes A
    Rev Med Chil; 1967 May; 95(5):276-8. PubMed ID: 5614809
    [No Abstract]   [Full Text] [Related]  

  • 51. [Clinical physiopathology of carcinoid tumors].
    ZAPATA APARICIO I
    Rev Esp Enferm Apar Dig Nutr; 1958; 17(7):751-72. PubMed ID: 13614859
    [No Abstract]   [Full Text] [Related]  

  • 52. [Internal malignant tumors and cutaneous symptoms].
    De Bersaques J; Dockx P
    Arch Belg Dermatol; 1974; 30(3):117-58. PubMed ID: 4377396
    [No Abstract]   [Full Text] [Related]  

  • 53. Tachykinins in endocrine tumors and the carcinoid syndrome.
    Cunningham JL; Janson ET; Agarwal S; Grimelius L; Stridsberg M
    Eur J Endocrinol; 2008 Sep; 159(3):275-82. PubMed ID: 18524798
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Kinin release in the carcinoid syndrome.
    Zeitlin IJ
    Lancet; 1971 Nov; 2(7732):1040. PubMed ID: 4108100
    [No Abstract]   [Full Text] [Related]  

  • 55. The carcinoid syndrome--20 years on.
    Scott Med J; 1972 Jul; 17(7):234-6. PubMed ID: 5041784
    [No Abstract]   [Full Text] [Related]  

  • 56. Diagnosis and treatment of malignant carcinoid syndrome.
    Ureles AL
    JAMA; 1974 Sep; 229(10):1346-8. PubMed ID: 4408182
    [No Abstract]   [Full Text] [Related]  

  • 57. Serotonin pathway in carcinoid syndrome: Clinical, diagnostic, prognostic and therapeutic implications.
    Fanciulli G; Ruggeri RM; Grossrubatscher E; Calzo FL; Wood TD; Faggiano A; Isidori A; Colao A;
    Rev Endocr Metab Disord; 2020 Dec; 21(4):599-612. PubMed ID: 32152781
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Carcinoid tumors of the digestive tract: serotonin].
    WEILL JP
    Strasb Med; 1959 May; 10(5):298-304. PubMed ID: 13668803
    [No Abstract]   [Full Text] [Related]  

  • 59. [Carcinoid: problems of pathology, biochemistry and therapy].
    Karkos J
    Pol Tyg Lek; 1971 Apr; 26(15):562-5. PubMed ID: 4325369
    [No Abstract]   [Full Text] [Related]  

  • 60. [Carcinoid syndrome. I. Histogenesis, general pathology, classification and physiology].
    Pérez Corral F; Díaz Recasens J; Ruíz Palomo F; Rapado A
    Rev Clin Esp; 1974 Jan; 132(1):1-10. PubMed ID: 4600558
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.